Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

類似資料

• Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
  著者:: Hofmann, Susanne, 等
  出版事項: (2019)
• Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
  著者:: Susanne Hofmann, 等
  出版事項: (2019)
• Chimeric antigen receptor transduced T cells: Tuning up for the next generation
  著者:: Maria‐Luisa Schubert, 等
  出版事項: (2017)
• Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma
  著者:: Korell, Felix, 等
  出版事項: (2021)
• Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19-positive malignancies
  著者:: Wang, Sanmei, 等
  出版事項: (2021)